| scholarly article | Q13442814 |
| P356 | DOI | 10.3171/JNS.1990.73.6.0918 |
| P698 | PubMed publication ID | 2230974 |
| P50 | author | Edward H. Oldfield | Q90685730 |
| P2093 | author name string | Bankiewicz KS | |
| Schwartz JP | |||
| Plunkett RJ | |||
| Miletich RS | |||
| Cummins AC | |||
| P433 | issue | 6 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 918-926 | |
| P577 | publication date | 1990-12-01 | |
| P1433 | published in | Journal of Neurosurgery | Q15708886 |
| P1476 | title | Long-term evaluation of hemiparkinsonian monkeys after adrenal autografting or cavitation alone | |
| P478 | volume | 73 |
| Q72332220 | A comparison of the behavioural effects of embryonic nigral grafts in the caudate nucleus and in the putamen of marmosets with unilateral 6-OHDA lesions |
| Q35655515 | A novel approach to neural transplantation in Parkinson's disease: use of polymer-encapsulated cell therapy |
| Q40972310 | Activated macrophages and microglia induce dopaminergic sprouting in the injured striatum and express brain-derived neurotrophic factor and glial cell line-derived neurotrophic factor |
| Q35209105 | CNS regeneration: clinical possibility or basic science fantasy? |
| Q37921767 | Cell replacement therapy for Parkinson's disease: how close are we to the clinic? |
| Q38079793 | Cell therapy for Parkinson's disease: what next? |
| Q33818127 | Cell-based therapies for Parkinson's disease: past, present, and future |
| Q40909193 | Cerebral transplantation for Parkinson's disease: current progress and future prospects |
| Q64878797 | Compensatory mechanisms in experimental and human parkinsonism: towards a dynamic approach |
| Q45986721 | Continuous intrathecal fluid infusions elevate nerve growth factor levels and prevent functional deficits after spinal cord ischemia. |
| Q39494122 | Delayed increase of tyrosine hydroxylase expression in rat nigrostriatal system after traumatic brain injury |
| Q48810893 | Dopaminergic innervation of striatal grafts placed into different sites of normal striatum: differences in the tyrosine hydroxylase immunoreactive growth pattern |
| Q42515795 | Embryonic ventral mesencephalic grafts to the substantia nigra of MPTP-treated monkeys: feasibility relevant to multiple-target grafting as a therapy for Parkinson's disease |
| Q38166648 | Gene therapy for the treatment of Parkinson's disease: the nature of the biologics expands the future indications |
| Q72534294 | Ibotenic acid lesions of the striatum reduce drug-induced rotation in the 6-hydroxydopamine-lesioned rat |
| Q41151744 | In vitro assessment of neurotrophic activity from the striatum of aging rats |
| Q41023740 | Induction of interleukin-1 associated with compensatory dopaminergic sprouting in the denervated striatum of young mice: model of aging and neurodegenerative disease. |
| Q40849460 | Inhibition of brain-derived neurotrophic factor and glial cell line-derived neurotrophic factor expression reduces dopaminergic sprouting in the injured striatum. |
| Q41331373 | Long‐term production of neurotrophic factors by astrocyte cultures from hemiparkinsonian rat brain |
| Q64869820 | Orphan neurones and amine excess: the functional neuropathology of Parkinsonism and neuropsychiatric disease |
| Q43925260 | Periwound dopaminergic sprouting is dependent on numbers of wound macrophages |
| Q33749480 | Promoter-activated expression of nerve growth factor for treatment of neurodegenerative diseases |
| Q48762940 | Putative chromaffin cell survival and enhanced host-derived TH-Fiber innervation following a functional adrenal medulla autograft for Parkinson's disease |
| Q48317002 | The biology and behaviour of intracerebral adrenal transplants in animals and man. |
| Q34120740 | The primate model of Parkinson's disease: its usefulness, limitations, and importance in directing future studies |
Search more.